Characterisation of 11 -hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat

Iwona Bujalska, Omar Durrani, Joseph Abbott, CU Onyimba, Pamela Khosla, AH Moosavi, Tristan Reuser, Paul Stewart, Jeremy Tomlinson, Elizabeth Walker, Saaeha Rauz

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Glucocorticoids (GCs) have a profound effect on adipose biology increasing tissue mass causing central obesity. The pre-receptor regulation of GCs by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) that activates cortisol from cortisone has been postulated as a fundamental mechanism underlying the metabolic syndrome mediating adipocyte hyperplasia and hypertrophy in the omental (OM) depot. Orbital adipose tissue (OF) is the site of intense inflammation and tissue remodelling in several orbital inflammatory disease states. In this study, we describe features of the GC metabolic pathways in normal human OF depot and compare it with subcutaneous (SC) and OM depots. Using an automated histological characterisation technique, OF adipocytes were found to be significantly smaller (parameters: area, maximum diameter and perimeter) than OM and SC adipocytes (P
Original languageEnglish
Pages (from-to)279-88
Number of pages10
JournalJournal of Endocrinology
Volume192
Issue number2
DOIs
Publication statusPublished - 1 Feb 2007

Fingerprint

Dive into the research topics of 'Characterisation of 11 -hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat'. Together they form a unique fingerprint.

Cite this